← Back to Screener
Avanos Medical, Inc. (AVNS)
Price$25.05
Value ScoreB
Growth ScoreD
Momentum ScoreA
Favorite Metrics
Price vs S&P 500 (26W)105.45%
Price vs S&P 500 (4W)1.02%
VGM Score60.55
Market Capitalization$1.17B
All Metrics
P/CF (Annual)15.70x
Book Value / Share (Quarterly)$16.76
P/TBV (Annual)0.79x
Revenue Growth (3Y)-5.08%
Cash Flow / Share (Quarterly)$0.16
Price vs S&P 500 (YTD)114.91%
Gross Margin (TTM)50.05%
Net Profit Margin (TTM)-10.39%
EPS (TTM)$-1.61
10-Day Avg Trading Volume1.86M
EPS Excl Extra (TTM)$-1.61
Revenue Growth (5Y)-0.38%
EPS (Annual)$-1.57
ROI (Annual)-8.30%
Gross Margin (Annual)50.47%
Net Profit Margin (5Y Avg)-13.95%
Cash / Share (Quarterly)$1.41
Revenue Growth QoQ (YoY)8.78%
ROA (Last FY)-6.79%
Revenue Growth TTM (YoY)3.87%
EBITD / Share (TTM)$-0.50
ROE (5Y Avg)-11.48%
Operating Margin (TTM)-8.80%
Cash Flow / Share (Annual)$0.93
P/B Ratio1.50x
P/B Ratio (Quarterly)0.83x
Net Income / Employee (Annual)$-31,900
EV / Revenue (TTM)1.68x
Net Interest Coverage (TTM)-13.39x
ROA (TTM)-7.03%
EPS Growth QoQ (YoY)-23.83%
EV / EBITDA (TTM)15.26x
EPS Incl Extra (Annual)$-1.57
Current Ratio (Annual)2.15x
Quick Ratio (Quarterly)1.29x
3-Month Avg Trading Volume1.23M
52-Week Price Return103.16%
EV / Free Cash Flow (Annual)27.97x
Revenue / Employee (TTM)$313,000
Tangible BV / Share (Quarterly)$14.30
P/S Ratio (Annual)1.67x
Asset Turnover (Annual)0.65x
52-Week High$25.49
Operating Margin (5Y Avg)-11.13%
EPS Excl Extra (Annual)$-1.57
CapEx CAGR (5Y)9.36%
Tangible BV CAGR (5Y)-9.68%
26-Week Price Return113.37%
Quick Ratio (Annual)1.17x
13-Week Price Return81.65%
Total Debt / Equity (Annual)0.13x
Current Ratio (Quarterly)2.48x
Enterprise Value$1.21B
Revenue / Share Growth (5Y)0.25%
Asset Turnover (TTM)0.68x
Book Value / Share Growth (5Y)-8.58%
Revenue / Employee (Annual)$306,600
Inventory Turnover (Annual)2.42x
Pretax Margin (Annual)-9.44%
Cash / Share (Annual)$1.93
3-Month Return Std Dev137.77%
Gross Margin (5Y Avg)53.22%
Net Income / Employee (TTM)$-32,500
EBITDA Interim CAGR (5Y)-2.17%
ROE (Last FY)-9.37%
Net Interest Coverage (Annual)-11.89x
EPS Basic Excl Extra (Annual)$-1.57
P/FCF (TTM)24.80x
Receivables Turnover (TTM)6.91x
EV / Free Cash Flow (TTM)160.74x
Total Debt / Equity (Quarterly)0.13x
EPS Incl Extra (TTM)$-1.61
Receivables Turnover (Annual)6.06x
ROI (TTM)-8.45%
P/S Ratio (TTM)1.64x
Pretax Margin (5Y Avg)-12.10%
Revenue / Share (Annual)$15.14
Tangible BV / Share (Annual)$14.22
Forward P/E25.05x
Price vs S&P 500 (52W)78.80%
Year-to-Date Return123.06%
5-Day Price Return0.00%
EPS Normalized (Annual)$-1.57
ROA (5Y Avg)-8.25%
Net Profit Margin (Annual)-10.40%
Month-to-Date Return1.01%
Cash Flow / Share (TTM)$0.94
EBITD / Share (Annual)$-0.49
Operating Margin (Annual)-8.78%
LT Debt / Equity (Annual)0.12x
P/CF (TTM)31.96x
ROI (5Y Avg)-9.95%
LT Debt / Equity (Quarterly)0.11x
EPS Basic Excl Extra (TTM)$-1.61
P/TBV (Quarterly)0.98x
P/B Ratio (Annual)0.67x
Inventory Turnover (TTM)2.56x
Pretax Margin (TTM)-9.54%
Book Value / Share (Annual)$16.75
Price vs S&P 500 (13W)73.40%
Beta1.56x
P/FCF (Annual)27.22x
Revenue / Share (TTM)$15.07
ROE (TTM)-9.55%
52-Week Low$9.30
vGradeB
gGradeD
mGradeA
vgmGradeB
Show chart for
Earnings Surprise History
Q1 260.22est. 0.14
Analyst Recommendations
Mar 2026
Apr 2026
May 2026
Jun 2026
2.17
2.17
2.17
2.17
Industry Peers — Orthopedic & Prosthetic Devices(33)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
AVNSAvanos Medical, Inc. | B | D | A | $25.05 |
| ISRGIntuitive Surgical Inc. | F | B | C | $422.06 |
| EWEdwards Lifesciences Corp | D | C | C | $85.96 |
| STESTERIS plc | C | B | C | $212.35 |
| ZBHZimmer Biomet Holdings, Inc. | B | C | C | $87.33 |
| ALGNAlign Technology Inc | B | C | C | $167.74 |
| SNNSmith & Nephew plc | B | C | C | $30.61 |
| MSAMine Safety Incorporated | B | C | C | $161.30 |
| ESTAEstablishment Labs Holdings Inc. | F | A | B | $74.31 |
| ENOVEnovis Corporation | B | D | C | $23.78 |
| CDRECadre Holdings, Inc. | C | C | D | $30.01 |
About
Avanos Medical Inc is a medical technology company specializing in pain management and patient care solutions. The company operates two primary segments: Specialty Nutrition Systems, which provides enteral feeding and neonatal products, and Pain Management and Recovery, which offers surgical pain solutions, pain pumps, and radiofrequency ablation treatments for chronic pain management.